ANIP icon

ANI Pharmaceuticals
ANIP

Overview Fund Activity

28 hedge funds and large institutions have $10.6M invested in ANI Pharmaceuticals in 2013 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 14 closing their positions.

Holders
28
Holders Change
-6
Holders Change %
-17.65%
% of All Funds
0.91%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
9
Increased
8
Reduced
10
Closed
14
Calls
$4.47M
Puts
$446K
Net Calls
+$4.03M
Net Calls Change
+$3.59M

Top Buyers

1
HVC
1
Healthcare Value Capital
New Jersey
$5.41M
2
KCM
2
Kennedy Capital Management
Missouri
$1.08M
3
ICOA
3
Investment Centers of America
North Dakota
$240K
4
BCM
4
Bridgeway Capital Management
Texas
$229K
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$281K

Top Sellers

1
Nomura Holdings
1
Nomura Holdings
Japan
$0
2
Northern Trust
2
Northern Trust
Illinois
$0
3
Renaissance Technologies
3
Renaissance Technologies
New York
$0
4
Goldman Sachs
4
Goldman Sachs
New York
$0
5
U
5
UBS
Switzerland
$6K
Name Holding Trade Value Shares
Change 		Shares
Change %
Renaissance Technologies
26
Renaissance Technologies
New York
– -$36K -5,959 Closed
Goldman Sachs
27
Goldman Sachs
New York
– -$33K -5,485 Closed
D.E. Shaw & Co
28
D.E. Shaw & Co
New York
– -$24K -3,927 Closed
GC
29
Guggenheim Capital
Illinois
– -$23K -3,761 Closed
ZIG
30
Zuckerman Investment Group
Illinois
– -$15K -2,509 Closed
Citadel Advisors
31
Citadel Advisors
Florida
– -$13K -2,244 Closed
State Street
32
State Street
Massachusetts
– -$13K -2,173 Closed
Citigroup
33
Citigroup
New York
– -$2K -229 Closed
ClearBridge Investments
34
ClearBridge Investments
New York
– -$1K -25 Closed
1
2